Forum for Science, Industry and Business
  • Sponsored by:
  • Siemens
  • Siemens
  • Siemens
Search our Site:

Topic (optional):

 

Home Special Topics Technology Offerings Content

Adenosine A2A Prodrugs - Phosphorylated A2A receptor agonist prodrugs as anti-inflammatory agents with improved tolerance

next article
10.04.2008

Anzeige

A2A agonists are well known for their anti-inflammatory action. A new class of compounds is presented that allows systemic and local application with reduced side effects due to activation of the prodrug at the site of inflammation. The invention discloses phosphorylated A2A receptor agonists and covers medicaments containing such compounds. It further discloses a method for identification of phosphorylated A2A receptor agonists. The disclosed compounds are applicable for the treatment of acute and chronic inflammation. Phosphorylated A2A receptor agonists can be considered as prodrugs, which are activated by dephosphorylation. The compounds are hydrolysed specifically by ecto-5’- nucleotidase (CD73), which is represented on the outer surface of endothelial cells of large and small arteries as well as on immune cells such as macrophages and Tlymphocytes. CD73 is also upregulated on the surfaces of inflamed tissues. Upregulation of CD73 has also been demonstrated for arteriosclerotic plaques. Therefore, activation of the prodrug directly at the site of inflammation reduced side effects can be expected.


Further Information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 0

Contact
Dipl.-Ing. Alfred Schillert

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

info@technologieallianz.de | Source: TechnologieAllianz e.V.
Further information: www.technologieallianz.de/angebote.php?sort=sag&id=1266&lang=en
www.technologieallianz.de

next article

B2B Search

Product / Service
Company / Organisation

Latest News

California study shows shade trees reduce summertime electricity use

07.01.2009 | Studies and Analyses

Jupiter-like Planets Could Form Around Twin Suns

07.01.2009 | Physics and Astronomy

Tackling climate change with new permits to pollute

07.01.2009 | Ecology, The Environment and Conservation

Event News

Annual Congress European Association of Urology: highlights in Stockholm

18.12.2008 | Event News

PRACE hosts First Scientific Conference

16.12.2008 | Event News

USM Conference Explores Issues And Challenges In The Global Construction Sector

10.12.2008 | Event News